Plasma miR-32 levels in non-small cell lung cancer patients receiving platinum-based chemotherapy can predict the effectiveness and prognosis of chemotherapy

BACKGROUND: Previous studies have shown that microRNA-32 (miRNA-32) is an exosome microRNA that affects the proliferation and metastasis of non-small cell lung cancer (NSCLC) cells. In this study, our goal was to assess the expression of plasma microRNA-32 and its potential as a biomarker to predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shuyuan, Li, Jing, Chen, Ling, Guo, Li, Ye, Mei, Wu, Yuanyuan, Ji, Quanjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824696/
https://www.ncbi.nlm.nih.gov/pubmed/31626089
http://dx.doi.org/10.1097/MD.0000000000017335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824696/
https://www.ncbi.nlm.nih.gov/pubmed/31626089
http://dx.doi.org/10.1097/MD.0000000000017335

Ejemplares similares